 Karin Payne
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Growth Plate | 8 | 2024 | 36 | 2.170 |
Why?
| | Chitosan | 8 | 2024 | 32 | 2.080 |
Why?
| | Regenerative Medicine | 4 | 2022 | 46 | 2.080 |
Why?
| | Osteogenesis | 9 | 2024 | 175 | 1.780 |
Why?
| | Tibia | 4 | 2023 | 170 | 1.330 |
Why?
| | Chondrogenesis | 8 | 2022 | 82 | 0.960 |
Why?
| | Biocompatible Materials | 6 | 2022 | 395 | 0.930 |
Why?
| | Salter-Harris Fractures | 3 | 2022 | 11 | 0.910 |
Why?
| | Alginates | 3 | 2024 | 46 | 0.890 |
Why?
| | Hydrogels | 9 | 2024 | 638 | 0.890 |
Why?
| | Vascular Endothelial Growth Factor A | 4 | 2020 | 530 | 0.810 |
Why?
| | Bone Resorption | 2 | 2022 | 79 | 0.780 |
Why?
| | Tibial Fractures | 1 | 2023 | 72 | 0.770 |
Why?
| | Musculoskeletal System | 1 | 2022 | 46 | 0.740 |
Why?
| | Rats, Sprague-Dawley | 8 | 2024 | 2406 | 0.720 |
Why?
| | Wound Healing | 3 | 2020 | 306 | 0.700 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2018 | 50 | 0.660 |
Why?
| | Spinal Fusion | 1 | 2022 | 230 | 0.630 |
Why?
| | Cartilage | 7 | 2022 | 180 | 0.630 |
Why?
| | Tissue Engineering | 10 | 2022 | 396 | 0.630 |
Why?
| | Stem Cells | 7 | 2022 | 577 | 0.620 |
Why?
| | Antibodies | 1 | 2020 | 398 | 0.610 |
Why?
| | Rats | 13 | 2024 | 5500 | 0.580 |
Why?
| | Bone Regeneration | 1 | 2017 | 23 | 0.560 |
Why?
| | Bone Development | 1 | 2017 | 49 | 0.550 |
Why?
| | Bone Diseases | 1 | 2017 | 57 | 0.540 |
Why?
| | Dependovirus | 2 | 2013 | 62 | 0.450 |
Why?
| | Cell Differentiation | 12 | 2024 | 1902 | 0.440 |
Why?
| | Transgenes | 2 | 2013 | 177 | 0.440 |
Why?
| | Cartilage, Articular | 6 | 2022 | 292 | 0.420 |
Why?
| | Muscle Cells | 2 | 2010 | 42 | 0.410 |
Why?
| | Animals | 28 | 2024 | 35361 | 0.400 |
Why?
| | Muscle, Skeletal | 7 | 2009 | 1614 | 0.370 |
Why?
| | Doxycycline | 1 | 2011 | 60 | 0.360 |
Why?
| | Hindlimb | 1 | 2011 | 122 | 0.350 |
Why?
| | Bone Morphogenetic Protein 4 | 8 | 2010 | 38 | 0.340 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 151 | 0.330 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 184 | 0.320 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 274 | 0.320 |
Why?
| | Disease Models, Animal | 7 | 2021 | 4063 | 0.320 |
Why?
| | Mechanical Phenomena | 2 | 2020 | 84 | 0.310 |
Why?
| | Bone Marrow Cells | 1 | 2010 | 300 | 0.310 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2010 | 359 | 0.300 |
Why?
| | Cartilage Diseases | 2 | 2018 | 39 | 0.290 |
Why?
| | Polyelectrolytes | 2 | 2024 | 15 | 0.280 |
Why?
| | Multipotent Stem Cells | 1 | 2007 | 19 | 0.280 |
Why?
| | Adult Stem Cells | 1 | 2007 | 39 | 0.270 |
Why?
| | Regeneration | 4 | 2021 | 180 | 0.270 |
Why?
| | Femur | 2 | 2023 | 244 | 0.250 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2007 | 328 | 0.230 |
Why?
| | Iridoids | 2 | 2022 | 4 | 0.230 |
Why?
| | Genetic Therapy | 5 | 2013 | 292 | 0.230 |
Why?
| | Rabbits | 3 | 2022 | 778 | 0.220 |
Why?
| | Gene Transfer Techniques | 4 | 2011 | 163 | 0.220 |
Why?
| | Cells, Cultured | 8 | 2018 | 4083 | 0.220 |
Why?
| | Genetic Vectors | 3 | 2013 | 312 | 0.220 |
Why?
| | Delayed-Action Preparations | 1 | 2024 | 173 | 0.210 |
Why?
| | Male | 14 | 2024 | 63681 | 0.200 |
Why?
| | Bone Morphogenetic Proteins | 4 | 2007 | 131 | 0.200 |
Why?
| | RANK Ligand | 1 | 2022 | 26 | 0.200 |
Why?
| | Osteoprotegerin | 1 | 2022 | 24 | 0.200 |
Why?
| | Osteoclasts | 1 | 2022 | 42 | 0.200 |
Why?
| | RNA, Small Interfering | 1 | 2024 | 587 | 0.190 |
Why?
| | Transfection | 2 | 2004 | 911 | 0.180 |
Why?
| | Permeability | 1 | 2020 | 157 | 0.160 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2019 | 63 | 0.160 |
Why?
| | Cell Culture Techniques | 1 | 2022 | 345 | 0.160 |
Why?
| | Rheology | 1 | 2020 | 90 | 0.160 |
Why?
| | Lower Extremity | 1 | 2023 | 404 | 0.160 |
Why?
| | Cross-Linking Reagents | 1 | 2020 | 205 | 0.160 |
Why?
| | Sex Characteristics | 2 | 2008 | 737 | 0.160 |
Why?
| | Biomimetic Materials | 1 | 2019 | 70 | 0.150 |
Why?
| | Stifle | 1 | 2018 | 4 | 0.150 |
Why?
| | Sex | 1 | 2007 | 4 | 0.140 |
Why?
| | Muscular Dystrophy, Animal | 1 | 2007 | 8 | 0.140 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 457 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 221 | 0.130 |
Why?
| | Pluripotent Stem Cells | 1 | 2007 | 77 | 0.130 |
Why?
| | Osteoarthritis | 1 | 2008 | 167 | 0.130 |
Why?
| | Bone Marrow Transplantation | 1 | 2018 | 274 | 0.130 |
Why?
| | DNA | 2 | 2004 | 1400 | 0.130 |
Why?
| | Muramidase | 1 | 2016 | 77 | 0.130 |
Why?
| | Bone and Bones | 2 | 2005 | 299 | 0.130 |
Why?
| | Humans | 16 | 2023 | 129650 | 0.130 |
Why?
| | Nanotechnology | 2 | 2004 | 122 | 0.120 |
Why?
| | Transcriptome | 1 | 2022 | 887 | 0.120 |
Why?
| | Child | 3 | 2023 | 20883 | 0.120 |
Why?
| | Calcium | 2 | 2020 | 1213 | 0.120 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 201 | 0.120 |
Why?
| | Orthopedics | 1 | 2007 | 135 | 0.120 |
Why?
| | Injections, Intra-Articular | 2 | 2013 | 46 | 0.120 |
Why?
| | Luciferases | 2 | 2013 | 148 | 0.110 |
Why?
| | Mice, Inbred C57BL | 5 | 2010 | 5440 | 0.110 |
Why?
| | Female | 8 | 2023 | 68776 | 0.110 |
Why?
| | Stem Cell Transplantation | 2 | 2009 | 166 | 0.110 |
Why?
| | Drug Delivery Systems | 1 | 2016 | 336 | 0.100 |
Why?
| | Chitin | 1 | 2003 | 8 | 0.100 |
Why?
| | Joint Diseases | 1 | 2013 | 56 | 0.100 |
Why?
| | Joints | 1 | 2013 | 100 | 0.100 |
Why?
| | Bone Substitutes | 1 | 2002 | 25 | 0.090 |
Why?
| | Emulsions | 2 | 2022 | 51 | 0.090 |
Why?
| | Tetracycline | 1 | 2011 | 12 | 0.090 |
Why?
| | Mice | 8 | 2010 | 16937 | 0.090 |
Why?
| | Transduction, Genetic | 4 | 2009 | 128 | 0.090 |
Why?
| | Chromones | 1 | 2010 | 45 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 958 | 0.090 |
Why?
| | Flavonoids | 1 | 2010 | 78 | 0.080 |
Why?
| | Cell Survival | 2 | 2010 | 1086 | 0.080 |
Why?
| | Morpholines | 1 | 2010 | 122 | 0.080 |
Why?
| | Glycosaminoglycans | 1 | 2010 | 84 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 385 | 0.080 |
Why?
| | Choristoma | 1 | 2009 | 21 | 0.080 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 400 | 0.080 |
Why?
| | Imidazoles | 1 | 2010 | 234 | 0.080 |
Why?
| | Trans-Activators | 1 | 2011 | 388 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 70 | 0.070 |
Why?
| | Rats, Nude | 3 | 2009 | 27 | 0.070 |
Why?
| | Cell Lineage | 2 | 2007 | 333 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2010 | 2391 | 0.070 |
Why?
| | Random Allocation | 2 | 2018 | 346 | 0.070 |
Why?
| | MyoD Protein | 1 | 2007 | 32 | 0.070 |
Why?
| | Enzyme Inhibitors | 1 | 2010 | 827 | 0.070 |
Why?
| | Pyridines | 1 | 2010 | 478 | 0.070 |
Why?
| | Hyaluronic Acid | 1 | 2009 | 214 | 0.070 |
Why?
| | Muscle Development | 1 | 2007 | 103 | 0.070 |
Why?
| | Mice, SCID | 1 | 2007 | 351 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2011 | 2548 | 0.060 |
Why?
| | Extracellular Matrix | 2 | 2022 | 504 | 0.060 |
Why?
| | Stress, Mechanical | 2 | 2022 | 467 | 0.060 |
Why?
| | Osteoarthritis, Knee | 1 | 2009 | 240 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2023 | 14518 | 0.060 |
Why?
| | Adolescent | 2 | 2017 | 20393 | 0.060 |
Why?
| | Chondrocytes | 3 | 2017 | 203 | 0.060 |
Why?
| | Cattle | 2 | 2022 | 976 | 0.060 |
Why?
| | Sex Factors | 1 | 2010 | 1968 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2717 | 0.050 |
Why?
| | Infant | 1 | 2017 | 9024 | 0.050 |
Why?
| | Injections | 2 | 2017 | 174 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2007 | 743 | 0.050 |
Why?
| | Desmin | 2 | 2007 | 24 | 0.050 |
Why?
| | Child, Preschool | 1 | 2017 | 10517 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 3144 | 0.050 |
Why?
| | Solvents | 1 | 2022 | 108 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2007 | 1356 | 0.050 |
Why?
| | Signal Transduction | 2 | 2019 | 4925 | 0.040 |
Why?
| | Smad Proteins | 1 | 2019 | 38 | 0.040 |
Why?
| | Ataxins | 1 | 2008 | 3 | 0.040 |
Why?
| | Ataxin-1 | 1 | 2008 | 4 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2018 | 69 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7086 | 0.040 |
Why?
| | Mice, Inbred mdx | 1 | 2007 | 13 | 0.040 |
Why?
| | Horses | 1 | 2018 | 107 | 0.040 |
Why?
| | Retroviridae | 2 | 2009 | 99 | 0.030 |
Why?
| | NIH 3T3 Cells | 2 | 2009 | 141 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2018 | 211 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2019 | 764 | 0.030 |
Why?
| | Myosin Heavy Chains | 1 | 2007 | 170 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 232 | 0.030 |
Why?
| | Arthroscopy | 1 | 2018 | 207 | 0.030 |
Why?
| | Gels | 1 | 2016 | 82 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2016 | 544 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 570 | 0.030 |
Why?
| | Middle Aged | 2 | 2019 | 31154 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2008 | 663 | 0.030 |
Why?
| | Cell Line | 2 | 2005 | 2781 | 0.030 |
Why?
| | Young Adult | 1 | 2010 | 12426 | 0.030 |
Why?
| | Recovery of Function | 1 | 2007 | 642 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2009 | 1698 | 0.030 |
Why?
| | Cnidaria | 1 | 2002 | 4 | 0.020 |
Why?
| | Biodegradation, Environmental | 1 | 2002 | 82 | 0.020 |
Why?
| | Osseointegration | 1 | 2002 | 56 | 0.020 |
Why?
| | Bone Transplantation | 1 | 2002 | 83 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2007 | 1269 | 0.020 |
Why?
| | Aged | 1 | 2010 | 22103 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1706 | 0.020 |
Why?
| | Calcification, Physiologic | 1 | 2009 | 34 | 0.020 |
Why?
| | Phenazines | 1 | 2009 | 9 | 0.020 |
Why?
| | Hyaline Cartilage | 1 | 2009 | 4 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2009 | 82 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2009 | 109 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2009 | 88 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 197 | 0.020 |
Why?
| | Drug Synergism | 1 | 2009 | 371 | 0.020 |
Why?
| | Solubility | 1 | 2009 | 235 | 0.020 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2007 | 19 | 0.020 |
Why?
| | Molecular Structure | 1 | 2009 | 482 | 0.020 |
Why?
| | Adult | 1 | 2010 | 35576 | 0.020 |
Why?
| | Time Factors | 2 | 2009 | 6556 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2006 | 77 | 0.020 |
Why?
| | Collagen Type II | 1 | 2006 | 47 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3408 | 0.020 |
Why?
| | Lac Operon | 1 | 2005 | 45 | 0.020 |
Why?
| | Proteoglycans | 1 | 2006 | 110 | 0.020 |
Why?
| | Antigens, Ly | 1 | 2005 | 44 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2005 | 92 | 0.020 |
Why?
| | Biomarkers | 2 | 2007 | 3973 | 0.020 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 39 | 0.020 |
Why?
| | Osteocytes | 1 | 2005 | 27 | 0.010 |
Why?
| | Antigens, CD34 | 1 | 2005 | 88 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2007 | 835 | 0.010 |
Why?
| | Vimentin | 1 | 2005 | 51 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2012 | 0.010 |
Why?
| | Biological Assay | 1 | 2005 | 118 | 0.010 |
Why?
| | Myoblasts | 1 | 2005 | 81 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2005 | 146 | 0.010 |
Why?
| | Muscles | 1 | 2005 | 322 | 0.010 |
Why?
| | Blotting, Western | 1 | 2005 | 1205 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2005 | 1156 | 0.010 |
Why?
| | Bone Density | 1 | 2005 | 471 | 0.010 |
Why?
| | Fibroblasts | 1 | 2005 | 948 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2005 | 1119 | 0.010 |
Why?
|
|
Payne's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|